loadpatents
Patent applications and USPTO patent grants for Geletneky; Karsten.The latest application filed is for "cancer therapy with a parvovirus combined with bevacizumab".
Patent | Date |
---|---|
Parvovirus formulation for treating tumors Grant 11,324,788 - Leuchs , et al. May 10, 2 | 2022-05-10 |
Cancer Therapy With A Parvovirus Combined With Bevacizumab App 20210060102 - Geletneky; Karsten ;   et al. | 2021-03-04 |
Cancer therapy with a parvovirus combined with bevacizumab Grant 10,813,959 - Geletneky , et al. October 27, 2 | 2020-10-27 |
Parvovirus Formulation For Treating Tumors App 20200215134 - Leuchs; Barbara ;   et al. | 2020-07-09 |
Parvovirus formulation for treating tumors Grant 10,624,935 - Leuchs , et al. | 2020-04-21 |
Use of parvovirus for eliminating cancer stem cells (CSCs) Grant 10,525,091 - Rommelaere , et al. J | 2020-01-07 |
Cancer therapy with a parvovirus combined with a BCL-2 inhibitor Grant 10,406,185 - Marchini , et al. Sept | 2019-09-10 |
Cancer Therapy With A Parvovirus Combined With A Bcl-2 Inhibitor App 20180117104 - MARCHINI; Antonio ;   et al. | 2018-05-03 |
Parvovirus Formulation For Treating Tumors App 20180110813 - Leuchs; Barbara ;   et al. | 2018-04-26 |
Cancer therapy with a parvovirus combined with a Bcl-2 inhibitor Grant 9,889,169 - Marchini , et al. February 13, 2 | 2018-02-13 |
Cancer Therapy With A Parvovirus Combined With Bevacizumab App 20180028583 - Geletneky; Karsten ;   et al. | 2018-02-01 |
Oncolytic virotherapy for prevention of tumor recurrence Grant 9,861,669 - Rommelaere , et al. January 9, 2 | 2018-01-09 |
USE OF PARVOVIRUS FOR ELIMINATING CANCER STEM CELLS (CSCs) App 20170266244 - Rommelaere; Jean ;   et al. | 2017-09-21 |
Use of parvovirus for eliminating cancer stem cells (CSCs) Grant 9,700,588 - Rommelaere , et al. July 11, 2 | 2017-07-11 |
Method for Cancer Therapy Based on Co-Administration of a Parvovirus and a Cytokine App 20160367609 - KIPRIJANOVA; Irina ;   et al. | 2016-12-22 |
Method for brain cancer therapy by co-administration of a parvovirus and interferon-gamma Grant 9,446,099 - Kiprijanova , et al. September 20, 2 | 2016-09-20 |
Cancer Therapy With A Parvovirus Combined With A Bcl-2 Inhibitor App 20160082056 - MARCHINI; Antonio ;   et al. | 2016-03-24 |
Parvovirus Cancer Therapy and Combination with Chemotherapy App 20140234261 - ROMMELAERE; Jean ;   et al. | 2014-08-21 |
USE OF PARVOVIRUS FOR ELIMINATING CANCER STEM CELLS (CSCs) App 20130209413 - Rommelaere; Jean ;   et al. | 2013-08-15 |
Parvovirus cancer therapy and combination with chemotherapy Grant 8,414,883 - Rommelaere , et al. April 9, 2 | 2013-04-09 |
Oncolytic Virotherapy for Prevention of Tumor Recurrence App 20120237483 - Rommelaere; Jean ;   et al. | 2012-09-20 |
Method for Cancer Therapy Based on a Co-Administration of a Parvovirus and a Cytokine App 20120213734 - Kiprijanova; Irina ;   et al. | 2012-08-23 |
Parvovirus Cancer Therapy and Combination with Chemotherapy App 20110020287 - Rommelaere; Jean ;   et al. | 2011-01-27 |
Use of parvovirus for brain tumor therapy Grant 7,179,456 - Rommelaere , et al. February 20, 2 | 2007-02-20 |
Adeno-associated virus-its diagnostic use with early abortion Grant 6,927,281 - Kern , et al. August 9, 2 | 2005-08-09 |
Use of parvovirus for brain tumor therapy App 20040220124 - Rommelaere, Jean ;   et al. | 2004-11-04 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.